Michaela Liedtke
MD
Associate Professor of Medicine (Hematology)
👥Biography 个人简介
Michaela Liedtke has evaluated inotuzumab ozogamicin (InO) for relapsed/refractory B-cell ALL and contributed to understanding hepatic toxicity including sinusoidal obstruction syndrome (SOS) in patients proceeding to allogeneic transplant. Her work has clarified the optimal sequencing and patient selection for InO therapy. She has also contributed to frontline ALL studies incorporating CD22-targeted therapy for bridge to transplant.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michaela Liedtke 的研究动态
Follow Michaela Liedtke's research updates
留下邮箱，当我们发布与 Michaela Liedtke（Stanford University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment